Heart Test Labs Files 8-K
Ticker: HSCSW · Form: 8-K · Filed: Jun 4, 2024 · CIK: 1468492
| Field | Detail |
|---|---|
| Company | Heart Test Laboratories, Inc. (HSCSW) |
| Form Type | 8-K |
| Filed Date | Jun 4, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $1.00 |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 8-k
TL;DR
Heart Test Labs filed a routine 8-K on 6/4 for an event on 6/3. Check full filing for details.
AI Summary
Heart Test Laboratories, Inc. filed an 8-K on June 4, 2024, reporting an event that occurred on June 3, 2024. The filing indicates the company is incorporated in Texas and provides its principal executive office address in Southlake, Texas. No specific financial details or significant events are detailed in the provided text excerpt.
Why It Matters
This filing is a standard corporate disclosure, indicating that Heart Test Laboratories, Inc. has submitted a current report to the SEC. Investors should review the full filing for details on any material events.
Risk Assessment
Risk Level: low — The provided text is a standard 8-K filing header and does not contain specific financial or operational information that would indicate a high risk.
Key Players & Entities
- Heart Test Laboratories, Inc. (company) — Registrant
- Texas (location) — State of Incorporation
- Southlake, Texas (location) — Principal Executive Offices
- June 3, 2024 (date) — Earliest event reported
- June 4, 2024 (date) — Date of Report
FAQ
What is the primary purpose of this 8-K filing?
This 8-K filing is a Current Report filed by Heart Test Laboratories, Inc. pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, indicating the reporting of an event on June 3, 2024.
When was this 8-K filing submitted to the SEC?
The filing was submitted on June 4, 2024.
Where is Heart Test Laboratories, Inc. incorporated?
Heart Test Laboratories, Inc. is incorporated in Texas.
What is the address of Heart Test Laboratories, Inc.'s principal executive offices?
The principal executive offices are located at 550 Reserve Street, Suite 360, Southlake, Texas 76092.
Does the provided text detail the specific event reported on June 3, 2024?
No, the provided text excerpt is primarily header information and does not detail the specific event that occurred on June 3, 2024.
Filing Stats: 715 words · 3 min read · ~2 pages · Grade level 11.1 · Accepted 2024-06-04 16:15:22
Key Financial Figures
- $1.00 — ompany has regained compliance with the $1.00 per share minimum bid price requirement
Filing Documents
- ea0207336-8k_hearttest.htm (8-K) — 38KB
- ea0207336ex99-1_hearttest.htm (EX-99.1) — 7KB
- image_001.jpg (GRAPHIC) — 4KB
- 0001213900-24-049670.txt ( ) — 266KB
- hscs-20240603.xsd (EX-101.SCH) — 3KB
- hscs-20240603_def.xml (EX-101.DEF) — 26KB
- hscs-20240603_lab.xml (EX-101.LAB) — 36KB
- hscs-20240603_pre.xml (EX-101.PRE) — 25KB
- ea0207336-8k_hearttest_htm.xml (XML) — 5KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. HEART TEST LABORATORIES, INC. Date: June 4, 2024 By: /s/ Andrew Simpson Name: Andrew Simpson Title: President, Chief Executive Officer and Chairman of the Board of Directors 2